Research and Markets has announced the addition of the "Gene Expression Analysis Market - Forecast (2016-2022)" report to their offering.

Gene expression analysis can be most simply described as the process of studying the way genes are transcribed to synthesize functional gene products functional RNA species or protein products. Gene expression analysis of gene regulation provides insights into normal cellular processes, such as differentiation, and abnormal or pathological processes. Globally, decreasing cost of DNA sequencing and increasing number of patients are expected to be the key growth drivers for the gene expression analysis market during the period of study.

Geographically, North America dominated the gene expression analysis market driven by world class infrastructure for R&D activities, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for gene expression analysis market.

Asia Pacific is projected to have the fastest growth, owing to the rapidly expanding presence of pharmaceutical giants in the region, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

Companies Mentioned:

  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina Inc.
  • Roche
  • Bio-Rad Laboratories
  • Agilent Technologies, Inc.
  • Affymetrix
  • GE Healthcare
  • Perkinelmer, Inc.
  • Oxford Gene Technology

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. Gene expression analysis Market, By Technology

7. Gene expression analysis Market, By Consumable

8. Gene expression analysis Market, By Application

9. Gene expression analysis Market, By Geography

10. Market Entropy

11. Company Profiles

12. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/7pcs52/gene_expression